Godrej Agrovet · forward-looking guidance across the available source record.
Guidance tracker
Management remains confident of double-digit revenue growth for FY27 but deferred specific mid-teas guidance to Q2-end pending clearer crop care visibility. Q2 assessment will determine where double-digit lands within the range.
Targeting 8-10% FFB volume growth annually over the 4-5 year LRP period, driven by 17,000 hectares annual area expansion, geographic diversification into Telangana and Northeast, and 50% of plantations in juvenile stage (0-4 years) approaching productive age.
Annual capex guidance maintained at ₹300-350 crore, covering oil palm area expansion, integrated palm oil complex in Karnataka (nursery, CPO mill, seed garden, refinery), and specialty fats facility—slated for September rollout.
Full-year revenue growth guidance upgraded from 20% to more than 20%, with Q1 at -8-9% being recovered in H2. CDMO salience expected at 50-52% of total revenue. EBITDA break-even achieved in Q1 versus ₹11 crore loss in Q1 FY26.
Management targets 15% revenue growth for Astec in FY27, led by CDMO segment growing faster than enterprise.
Management expects to sustain EBITDA margins in the 28-30% range for the crop protection business over the medium term.
Management reiterated guidance for Astec to achieve EBITDA breakeven for the full year FY26.
Management expects steady-state FFB tonnage growth of 12-15% CAGR, supported by acreage expansion and productivity improvements.